{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:54:01Z","timestamp":1782219241805,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"2026 Innovation Project of Youjiang Medical University for Nationalities Graduate Education","award":["YXCXJH2026001"],"award-info":[{"award-number":["YXCXJH2026001"]}]},{"name":"the 2025 National Undergraduate Training Program on Innovation and Entrepreneurship of Youjiang Medical University for Nationalities","award":["202510599027"],"award-info":[{"award-number":["202510599027"]}]},{"name":"Guangxi Young Elite Scientist Sponsorship Program","award":["GXYESS2025011"],"award-info":[{"award-number":["GXYESS2025011"]}]},{"name":"General Support Policy for Young Talent (the First Batch) of Guangxi Zhuang Autonomous Region","award":["to Zongling Liu"],"award-info":[{"award-number":["to Zongling Liu"]}]},{"name":"High level Talent Research Launch Fund of Xinjiang Institute of Technology","award":["XJLG2023G001"],"award-info":[{"award-number":["XJLG2023G001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12157-3","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:27:15Z","timestamp":1782217635000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PYCR1 modulates ferroptosis and malignant phenotypes of clear cell renal cell carcinoma through proline biosynthesis"],"prefix":"10.1007","volume":"53","author":[{"given":"Jizhe","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minlin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyue","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangui","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"12157_CR1","doi-asserted-by":"publisher","unstructured":"Clifford SC, Prowse AH, Affara NA, Buys CH, Maher ER (1998) Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis. Genes Chromosomes Cancer 22:200\u2013209.https:\/\/doi.org\/10.1002\/(sici)1098-2264(199807)22:3%3C200::aid-gcc5%3E3.0.co;2-#","DOI":"10.1002\/(sici)1098-2264(199807)22:3%3C200::aid-gcc5%3E3.0.co;2-#"},{"key":"12157_CR2","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.kint.2024.12.003","volume":"107","author":"A Catalano","year":"2025","unstructured":"Catalano A, Haas LS, Zodel K, Adlesic M, Cuomo F, Peighambari A, Metzger P, Huang H, Haug S, K\u00f6ttgen A et al (2025) Mutations in tumor suppressor genes Vhl and Rassf1a cause DNA damage, chromosomal instability and induce gene expression changes characteristic of clear cell renal cell carcinoma. Kidney Int 107:666\u2013686. https:\/\/doi.org\/10.1016\/j.kint.2024.12.003","journal-title":"Kidney Int"},{"key":"12157_CR3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2174\/0109298665357331250416081850","volume":"32","author":"Z Huang","year":"2025","unstructured":"Huang Z, Du Y, Yin H, Wang G, Xu T (2025) Inhibition of Canonical Wnt Signaling in Renal Cell Carcinoma Bone Metastasis: An Immunohistochemical Analysis of DKK1 and LRP5 Expression. Protein Pept Lett 32:327\u2013334. https:\/\/doi.org\/10.2174\/0109298665357331250416081850","journal-title":"Protein Pept Lett"},{"key":"12157_CR4","doi-asserted-by":"publisher","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","volume":"3","author":"JJ Hsieh","year":"2017","unstructured":"Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M, Heng DY, Larkin J, Ficarra V (2017) Renal cell carcinoma. Nat Rev Dis Primers 3:17009. https:\/\/doi.org\/10.1038\/nrdp.2017.9","journal-title":"Nat Rev Dis Primers"},{"key":"12157_CR5","doi-asserted-by":"publisher","unstructured":"Rysz J, \u0141awi\u0144ski J, Franczyk B, Gluba-Sagr A (2025) Immune Checkpoint Inhibitors in Clear Cell Renal Cell Carcinoma (ccRCC). Int J Mol Sci 26. https:\/\/doi.org\/10.3390\/ijms26125577","DOI":"10.3390\/ijms26125577"},{"key":"12157_CR6","doi-asserted-by":"publisher","first-page":"7038","DOI":"10.1111\/febs.16059","volume":"289","author":"J Liu","year":"2022","unstructured":"Liu J, Kang R, Tang D (2022) Signaling pathways and defense mechanisms of ferroptosis. FEBS J 289:7038\u20137050. https:\/\/doi.org\/10.1111\/febs.16059","journal-title":"FEBS J"},{"key":"12157_CR7","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2174\/0109298665333926240927074528","volume":"31","author":"H Zhong","year":"2024","unstructured":"Zhong H, Liu H, Fu Q (2024) Ferroptosis as a Therapeutic Target in Neurodegenerative Diseases: Exploring the Mechanisms and Potential of Treating Alzheimer\u2019s Disease and Parkinson\u2019s Disease. Protein Pept Lett 31:759\u2013772. https:\/\/doi.org\/10.2174\/0109298665333926240927074528","journal-title":"Protein Pept Lett"},{"key":"12157_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","volume":"12","author":"Y Mou","year":"2019","unstructured":"Mou Y, Wang J, Wu J, He D, Zhang C, Duan C, Li B (2019) Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol 12:34. https:\/\/doi.org\/10.1186\/s13045-019-0720-y","journal-title":"J Hematol Oncol"},{"key":"12157_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40170-022-00290-z","volume":"10","author":"TD Klasson","year":"2022","unstructured":"Klasson TD, LaGory EL, Zhao H, Huynh SK, Papandreou I, Moon EJ, Giaccia AJ (2022) ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma. Cancer Metab 10:14. https:\/\/doi.org\/10.1186\/s40170-022-00290-z","journal-title":"Cancer Metab"},{"key":"12157_CR10","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1158\/0008-5472.CAN-22-4001","volume":"83","author":"K Chang","year":"2023","unstructured":"Chang K, Chen Y, Zhang X, Zhang W, Xu N, Zeng B, Wang Y, Feng T, Dai B, Xu F et al (2023) DPP9 Stabilizes NRF2 to Suppress Ferroptosis and Induce Sorafenib Resistance in Clear Cell Renal Cell Carcinoma. Cancer Res 83:3940\u20133955. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-4001","journal-title":"Cancer Res"},{"key":"12157_CR11","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1038\/s42003-025-08900-4","volume":"8","author":"W Xue","year":"2025","unstructured":"Xue W, Wu Z, Li J, Jin P, Zhu Y, Li Z, Wang Z, Li Z, Fei X (2025) Therapeutic targeting SPI1 in combination with erastin promotes ferroptosis in ccRCC. Commun Biol 8:1772. https:\/\/doi.org\/10.1038\/s42003-025-08900-4","journal-title":"Commun Biol"},{"key":"12157_CR12","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41419-023-06057-8","volume":"14","author":"W Xue","year":"2023","unstructured":"Xue W, Jian W, Meng Y, Wang T, Cai L, Yu Y, Yu Y, Xia Z, Zhang C (2023) Knockdown of SETD2 promotes erastin-induced ferroptosis in ccRCC. Cell Death Dis 14:539. https:\/\/doi.org\/10.1038\/s41419-023-06057-8","journal-title":"Cell Death Dis"},{"key":"12157_CR13","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s42255-022-00582-0","volume":"4","author":"EJ Kay","year":"2022","unstructured":"Kay EJ, Paterson K, Riera-Domingo C, Sumpton D, D\u00e4britz JHM, Tardito S, Boldrini C, Hernandez-Fernaud JR, Athineos D, Dhayade S et al (2022) Cancer-associated fibroblasts require proline synthesis by PYCR1 for the deposition of pro-tumorigenic extracellular matrix. Nat Metab 4:693\u2013710. https:\/\/doi.org\/10.1038\/s42255-022-00582-0","journal-title":"Nat Metab"},{"key":"12157_CR14","doi-asserted-by":"publisher","first-page":"e70045","DOI":"10.1002\/ctm2.70045","volume":"14","author":"H Wang","year":"2024","unstructured":"Wang H, Xu M, Zhang T, Pan J, Li C, Pan B, Zhou L, Huang Y, Gao C, He M et al (2024) PYCR1 promotes liver cancer cell growth and metastasis by regulating IRS1 expression through lactylation modification. Clin Transl Med 14:e70045. https:\/\/doi.org\/10.1002\/ctm2.70045","journal-title":"Clin Transl Med"},{"key":"12157_CR15","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1038\/s12276-025-01577-z","volume":"57","author":"JH Shin","year":"2025","unstructured":"Shin JH, Kim JY, Kim M, Kang Y, Lee H, Choi B, Lee JS, Kwon D, Kim SH, Sung Y et al (2025) PYCR1 drives lung cancer progression through functional interactions with EGFR and TLR signaling pathways. Exp Mol Med 57:2559\u20132573. https:\/\/doi.org\/10.1038\/s12276-025-01577-z","journal-title":"Exp Mol Med"},{"key":"12157_CR16","doi-asserted-by":"publisher","first-page":"1226044","DOI":"10.3389\/fcell.2023.1226044","volume":"11","author":"HT Endale","year":"2023","unstructured":"Endale HT, Tesfaye W, Mengstie TA (2023) ROS induced lipid peroxidation and their role in ferroptosis. Front Cell Dev Biol 11:1226044. https:\/\/doi.org\/10.3389\/fcell.2023.1226044","journal-title":"Front Cell Dev Biol"},{"key":"12157_CR17","doi-asserted-by":"publisher","first-page":"157884","DOI":"10.1016\/j.phymed.2026.157884","volume":"152","author":"Y Tian","year":"2026","unstructured":"Tian Y, Ren C, Wang H, Yang W, Ye J, Cai B, Yang K, Chi Y, Zhang D, Pan X et al (2026) Celastrol induces ferroptosis in ccRCC through TEF-Driven ACOX2 upregulation and metabolic reprogramming. Phytomedicine 152:157884. https:\/\/doi.org\/10.1016\/j.phymed.2026.157884","journal-title":"Phytomedicine"},{"key":"12157_CR18","doi-asserted-by":"publisher","first-page":"1473203","DOI":"10.3389\/fimmu.2024.1473203","volume":"15","author":"C He","year":"2024","unstructured":"He C, Li Q, Wu W, Liu K, Li X, Zheng H, Lai Y (2024) Ferroptosis-associated genes and compounds in renal cell carcinoma. Front Immunol 15:1473203. https:\/\/doi.org\/10.3389\/fimmu.2024.1473203","journal-title":"Front Immunol"},{"key":"12157_CR19","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41419-025-07698-7","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang Y, Lu J, Lin B, Chen J, Lin F, Zheng Q, Xue X, Wei Y, Chen S, Xu N (2025) Integrated analysis of MIOX gene in prognosis of clear-cell renal cell carcinoma. Cell Death Dis 16:368. https:\/\/doi.org\/10.1038\/s41419-025-07698-7","journal-title":"Cell Death Dis"},{"key":"12157_CR20","doi-asserted-by":"publisher","first-page":"101667","DOI":"10.1016\/j.tranon.2023.101667","volume":"32","author":"L Zhang","year":"2023","unstructured":"Zhang L, Zhao X, Wang E, Yang Y, Hu L, Xu H, Zhang B (2023) PYCR1 promotes the malignant progression of lung cancer through the JAK-STAT3 signaling pathway via PRODH-dependent glutamine synthesize. Transl Oncol 32:101667. https:\/\/doi.org\/10.1016\/j.tranon.2023.101667","journal-title":"Transl Oncol"},{"key":"12157_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.14670\/HH-18-762","volume":"40","author":"M Zhang","year":"2025","unstructured":"Zhang M, Bi B, Liu G, Fan X (2025) PYCR1 expresses in cancer-associated fibroblasts and accelerates the progression of C6 glioblastoma. Histol Histopathol 40:89\u2013100. https:\/\/doi.org\/10.14670\/HH-18-762","journal-title":"Histol Histopathol"},{"key":"12157_CR22","doi-asserted-by":"publisher","first-page":"e70017","DOI":"10.1002\/jgm.70017","volume":"27","author":"Y Meng","year":"2025","unstructured":"Meng Y, Feng H, Li B, Xie Y, Li Z, Li Z, Li X (2025) PYCR1 Promotes Esophageal Squamous Cell Carcinoma by Interacting With EGFR to Affecting the PI3K\/Akt\/mTOR Signaling Pathway. J Gene Med 27:e70017. https:\/\/doi.org\/10.1002\/jgm.70017","journal-title":"J Gene Med"},{"key":"12157_CR23","doi-asserted-by":"publisher","first-page":"2546219","DOI":"10.1080\/15384047.2025.2546219","volume":"26","author":"Z Li","year":"2025","unstructured":"Li Z, Jiang Q, Yang Q, Zhou Y, Wang J (2025) Hypoxia-induced PYCR1 regulates glycolysis and histone lactylation to promote bladder cancer progression and metastasis via SLC6A14\/Glutamine metabolism. Cancer Biol Ther 26:2546219. https:\/\/doi.org\/10.1080\/15384047.2025.2546219","journal-title":"Cancer Biol Ther"},{"key":"12157_CR24","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.biopha.2018.12.089","volume":"111","author":"D Wang","year":"2019","unstructured":"Wang D, Wang L, Zhang Y, Yan Z, Liu L, Chen G (2019) PYCR1 promotes the progression of non-small-cell lung cancer under the negative regulation of miR-488. Biomed Pharmacother 111:588\u2013595. https:\/\/doi.org\/10.1016\/j.biopha.2018.12.089","journal-title":"Biomed Pharmacother"},{"key":"12157_CR25","doi-asserted-by":"publisher","first-page":"937","DOI":"10.21037\/atm-19-4402","volume":"8","author":"S Xiao","year":"2020","unstructured":"Xiao S, Li S, Yuan Z, Zhou L (2020) Pyrroline-5-carboxylate reductase 1 (PYCR1) upregulation contributes to gastric cancer progression and indicates poor survival outcome. Ann Transl Med 8:937. https:\/\/doi.org\/10.21037\/atm-19-4402","journal-title":"Ann Transl Med"},{"key":"12157_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10863-021-09887-3","volume":"53","author":"S Du","year":"2021","unstructured":"Du S, Sui Y, Ren W, Zhou J, Du C (2021) PYCR1 promotes bladder cancer by affecting the Akt\/Wnt\/\u03b2-catenin signaling. J Bioenerg Biomembr 53:247\u2013258. https:\/\/doi.org\/10.1007\/s10863-021-09887-3","journal-title":"J Bioenerg Biomembr"},{"key":"12157_CR27","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.7150\/jca.61498","volume":"13","author":"H Wang","year":"2022","unstructured":"Wang H, Mao W, Lou W, Jin D, Wu W, Wang D, Kuang T, Rong Y, Xu X, Zhang L (2022) PYCR1: A Potential Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma. J Cancer 13:1501\u20131511. https:\/\/doi.org\/10.7150\/jca.61498","journal-title":"J Cancer"},{"key":"12157_CR28","doi-asserted-by":"publisher","first-page":"119639","DOI":"10.1016\/j.bbamcr.2023.119639","volume":"1871","author":"RJ Mailloux","year":"2024","unstructured":"Mailloux RJ (2024) Proline and dihydroorotate dehydrogenase promote a hyper-proliferative state and dampen ferroptosis in cancer cells by rewiring mitochondrial redox metabolism. Biochim Biophys Acta-Mol Cell Res 1871:119639. https:\/\/doi.org\/10.1016\/j.bbamcr.2023.119639","journal-title":"Biochim Biophys Acta-Mol Cell Res"},{"key":"12157_CR29","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/s00726-021-03047-y","volume":"53","author":"Y Li","year":"2021","unstructured":"Li Y, Bie J, Song C, Liu M, Luo J (2021) PYCR, a key enzyme in proline metabolism, functions in tumorigenesis. Amino Acids 53:1841\u20131850. https:\/\/doi.org\/10.1007\/s00726-021-03047-y","journal-title":"Amino Acids"},{"key":"12157_CR30","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev.nutr.012809.104638","volume":"30","author":"JM Phang","year":"2010","unstructured":"Phang JM, Liu W, Zabirnyk O (2010) Proline metabolism and microenvironmental stress. Annu Rev Nutr 30:441\u2013463. https:\/\/doi.org\/10.1146\/annurev.nutr.012809.104638","journal-title":"Annu Rev Nutr"},{"key":"12157_CR31","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1089\/ars.2012.5074","volume":"19","author":"X Liang","year":"2013","unstructured":"Liang X, Zhang L, Natarajan SK, Becker DF (2013) Proline mechanisms of stress survival. Antioxid Redox Signal 19:998\u20131011. https:\/\/doi.org\/10.1089\/ars.2012.5074","journal-title":"Antioxid Redox Signal"},{"key":"12157_CR32","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, Roberts MA, Tong B, Maimone TJ, Zoncu R et al (2019) The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature 575:688\u2013692. https:\/\/doi.org\/10.1038\/s41586-019-1705-2","journal-title":"Nature"},{"key":"12157_CR33","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41594-026-01760-4","volume":"33","author":"FAD-dependent stabilization of FSP1 promotes ferroptosis resistance","year":"2026","unstructured":"FAD-dependent stabilization of FSP1 promotes ferroptosis resistance (2026) Nat Struct Mol Biol 33:380\u2013381. https:\/\/doi.org\/10.1038\/s41594-026-01760-4","journal-title":"Nat Struct Mol Biol"},{"key":"12157_CR34","doi-asserted-by":"publisher","unstructured":"Zhuang J, Song Y, Ye Y, He S, Ma X, Zhang M, Ni J, Wang J, Xia W (2019) PYCR1 interference inhibits cell growth and survival via c-Jun N-terminal kinase\/insulin receptor substrate 1 (JNK\/IRS1) pathway in hepatocellular cancer. J Transl Med 17. https:\/\/doi.org\/10.1186\/s12967-019-2091-0","DOI":"10.1186\/s12967-019-2091-0"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12157-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12157-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12157-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:27:16Z","timestamp":1782217636000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12157-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12157"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12157-3","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"22 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No specific permits were needed for these experiments. The authors confirm that all methods used in the study were conducted in accordance with relevant institutional, national, and international guidelines and legislation, and that this study did not involve any protected species.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"JJ Zhou, YT Zhou, HF Li: Validation, Methodology, Formal analysis, Writing \u2013 review and editing. ML Jiang, YY Guo, DL Xie. ZL Liu, SG Yi: Writing - original draft, Funding acquisition, Conceptualization.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authorship contribution"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institution Review Board Statement"}}],"article-number":"984"}}